Asked by

20 Minutes

last week, Bryan Coquard admitted that the rise in Covid-19 cases was generating "a lot of stress until the next tests", as the Tour approached.

The last ones passed by the Cofidis sprinter revealed that he had in turn been infected, like other runners before him.

#TDF2022 @bryancoquard replaced by @PerichonPLuc

Successive tests carried out by the medical staff of the Cofidis team revealed a positive return to Covid-19.

In accordance with team policy and in agreement with ASO and the UCI, he will not be at the start tomorrow @LeTour

— Team Cofidis (@TeamCOFIDIS) June 30, 2022

Access to this content has been blocked to respect your choice of consent

By clicking on "


", you accept the deposit of cookies by external services and will thus have access to the content of our partners


And to better remunerate 20 Minutes, do not hesitate to accept all cookies, even for one day only, via our "I accept for today" button in the banner below.

More information on the Cookie Management Policy page.

"In accordance with the policy of the team, in agreement with ASO (organizer of the event) and the UCI [the International Federation], he will not participate in the Tour de France", indicates the northern formation this Thursday, at the the day before the start of the Grande Boucle in Copenhagen.

The “curse” continues

Arrived this winter from the B&B Hotels team and victorious in two races in February, Coquard (30) will be replaced by Pierre-Luc Périchon.

The 35-year-old runner will compete for the sixth time in the biggest race in the world.

The sixth participation of the "Coq" will wait for next year, and its first stage victory too, after two second places in 2015 and 2016.


Tour de France 2022: "I tell myself that I have already almost won and that it is possible", assures Bryan Coquard, in search of a stage victory


Tour de France 2022: French champion Florian Sénéchal drafted by Quick-Step after a case of Covid

  • Sport

  • Cycling

  • Tour de France 2022

  • Covid-19

  • Coronavirus

  • Cofidis